Page last updated: 2024-08-24

tenofovir and Liver Neoplasms

tenofovir has been researched along with Liver Neoplasms in 204 studies

Research

Studies (204)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (1.47)	29.6817
2010's	61 (29.90)	24.3611
2020's	140 (68.63)	2.80

Authors

Authors	Studies
Burns, GS; Hall, SAL; Sundararajan, V; Thompson, A; Visvanathan, K; Vogrin, S; Wawryk, O	1
Choi, WM; Kim, WR; Lim, YS; Wong, GL; Yip, TC	1
Jin, YJ; Lee, JW; Lim, JH; Suh, YJ; Yu, JH	1
Ahn, SB; Berg, T; Buti, M; Calleja, JL; Cho, YK; Dalekos, GN; Goulis, J; Idilman, R; Jang, ES; Jang, MJ; Janssen, HLA; Jeong, SW; Jun, DW; Jung, YJ; Kim, HS; Kim, HY; Kim, SE; Kim, SU; Kim, YJ; Lampertico, P; Lee, HA; Lee, HC; Lee, JH; Lee, YB; Lim, YS; Manolakopoulos, S; Nam, JY; Papatheodoridis, GV; Park, SY; Seo, YS; Shim, JJ; Sinn, DH; Sohn, JH; Sypsa, V; Yoon, EL; Yoon, JH	1
Dai, J; Gao, F; Leng, S; Li, C; Peng, W; Qi, W; Ran, S; Shen, J; Wen, T; Wu, Y; Zhang, X; Zhang, Y	1
Jeong, S; Kim, HI; Shin, HP	1
Ahn, SH; Chon, HY; Kim, SU; Kim, YJ; Lee, JH; Sinn, DH; Yoon, JH	1
Furquim d'Almeida, A; Ho, E; Van Hees, S; Vanwolleghem, T	1
Dai, J; Jiang, K; Leng, S; Li, C; Qi, W; Ran, S; Shen, J; Wen, T; Zhang, Y	1
Huo, RR; Li, MJ; Li, RH; Papatheodoridis, G; Yuan, BH; Zhong, JH	1
Chokkalingam, AP; Flaherty, J; Gaggar, A; Gordon, SC; Jump, B; Kim, WR; Lu, M; Ramroth, H; Telep, LE	1
Chen, MS; Fu, YZ; Hou, JY; Hu, ZL; Li, WX; Wang, XH; Xu, L; Zhang, YJ; Zhou, QF; Zhou, ZG	1
Aghemo, A; Masetti, C; Pugliese, N; Viganò, M	1
El-Serag, HB; Hsu, YC; Kanwal, F; Kim, H; Kramer, JR; Richardson, PA	1
Huang, SJ; Huang, Y; Huang, ZH; Liu, XH; Lu, GY; Qiu, LX; Su, YY; Wang, YB; Wu, T; Xia, NS; Yao, XM; Yuan, Q; Zhang, J; Zhong, GH	1
Adali, G; Bahadir, O; Degirmenci Salturk, AG; Doganay, HL; Gokcen, P; Guzelbulut, F; Kanatsiz, E; Kiyak, M; Ozdil, K; Ozturk, O	1
Choi, J; Choi, WM; Kim, KM; Lee, D; Lee, HC; Lim, J; Lim, YS; Shim, JH	1
Chen, M; Hou, J; Hu, Z; Wang, J; Xu, L; Zeng, H; Zhang, Y; Zhou, Z	1
Chen, LW; Chien, CH; Chien, RN; Hu, CC; Huang, TS; Liang, KH; Lin, CL; Lin, YL; Shyu, YC; Yeh, CT	1
Chokkalingam, AP; Kim, WR; Telep, LE	1
Tonthat, AV; Zhou, K	1
Chang, ML; Cheng, JS; Chien, RN; Lee, KC; Liaw, YF	1
Fung, J; Huang, DQ; Kim, BK; Lim, GEH; Lim, KE; Lim, WH; Loomba, R; Muthiah, MD; Ng, CH; Nguyen, MH; Syn, N; Tamaki, N; Tan, DJH; Tang, ASP; Tay, PWL; Teng, MLP	1
Ahn, SH; Kim, BK; Oh, J; Yoon, JH; Yun, B	1
Chen, J; Hu, X; Li, Q; Li, R; Yuan, G; Zang, M	1
Akahane, T; Inoue, J; Iwata, T; Kimura, O; Kobayashi, T; Masamune, A; Nakamura, T; Niitsuma, H; Ninomiya, M; Onuki, M; Sano, A; Sato, K; Sato, T; Sawahashi, S; Takai, S; Tsuruoka, M	1
Brakenhoff, SM; de Knegt, RJ; de Man, RA; Katwaroe, WK; Sonneveld, MJ; van der Meer, AJP; van der Spek, DPC; van Kleef, LA	1
Afzalpurkar, S; Agrawal, D; Angadi, S; Giri, S; Gopan, A; Sundaram, S	1
Hou, J; Li, Y; Qiang, Z; Zhang, Y	1
Brooks-Rooney, C; Cant, H; Chen, CH; Chen, CY; Choi, WM; Curteis, T; Huang, YH; Jin, YJ; Jun, DW; Kim, JW; Kim, WR; Lim, YS; Park, NH; Peng, CY; Shin, HP; Shin, JW; Wong, GL; Yang, YH; Yee, LJ; Yip, TC	1
Hu, L; Lyu, C; Shao, J; Wang, Y; Zhang, L	1
Berzigotti, A; Bonnet, F; Günthard, HF; Leleux, O; Limacher, A; Mocroft, A; Peters, L; Ramírez Mena, A; Rauch, A; Rockstroh, JK; Roumet, M; Smit, C; Surial, B; van der Valk, M; Wandeler, G	1
Gao, F; Li, C; Qi, W; Shen, J; Zhang, Y	1
Cheng, H; Guo, Y; Tang, K; Wang, H	1
Chan, HL; Hui, VW; Lai, JC; Lai, MS; Liang, LY; Tse, YK; Wong, GL; Wong, VW; Yip, TC	1
Ahn, SB; Chen, CH; Chen, CY; Cho, YK; Choi, WM; Hur, MH; Jang, MJ; Jeong, SW; Jin, YJ; Jun, DW; Kim, HS; Kim, HY; Kim, SE; Kim, SU; Kim, YJ; Lee, HA; Lee, HC; Lee, JH; Lim, YS; Park, MK; Park, SY; Peng, CY; Seo, YS; Shim, JJ; Shin, HP; Sinn, DH; Sohn, JH; Wong, GL; Yip, TC; Yoon, EL; Yoon, JH	1
Chang, CC; Chiou, JF; Hou, MC; Huang, YH; Huo, TI; Kao, WY; Lee, HL; Su, CW; Tan, EC; Wu, JC	1
Lu, H; Xia, X; Xiong, B; Zheng, C	1
Mizokami, M; Murata, K	1
Barreiro, P; Corral, O; Mendoza, C; Moreno-Torres, V; Soriano, V	1
Borghi, M; Cerini, F; Ceriotti, F; Degasperi, E; Facchetti, F; Farina, E; Gentile, C; Lampertico, P; Loglio, A; Monico, S; Perbellini, R; Primignani, M; Tosetti, G; Uceda Renteria, SC; Viganò, M	1
Hu, X; Li, Y; Luo, H; Qin, B; Tan, G	1
Chuan, L; Linye, H; Tianfu, W; Xiaoyun, Z; Zhihui, L; Zijing, X	1
Arai, K; Hayakawa, N; Honda, M; Horii, R; Kagaya, T; Kaneko, S; Kawaguchi, K; Komura, T; Mizukoshi, E; Nio, K; Nishikawa, M; Orita, N; Sakai, Y; Shimakami, T; Shimode, T; Takatori, H; Terashima, T; Yamashita, T	1
Ahn, SH; Chon, YE; Kim, BK; Kim, DY; Kim, H; Kim, SU; Lee, HW; Lee, JS; Park, JY; Park, SY; Park, T; Seo, YS	1
Cho, JY; Choi, D; Choi, Y; Hwang, S; Joo, DJ; Kang, KJ; Kim, BW; Kim, DG; Kim, DS; Kim, MS; Lee, JG; Nah, YW; Rhu, J; Ryu, JH; Yang, JD; You, YK	1
Bojang, L; Ceesay, A; Chemin, I; D'Alessandro, U; Hateley, C; Ingiliz, P; Lemoine, M; Mendy, M; Ndow, G; Njai, HF; Njie, R; Opoku, E; Shimakawa, Y; Takao, Y; Tamba, S; Thursz, M; Vo-Quang, E; Warsop, Z	1
Jiang, L; Lou, Z; Pan, L; Ruan, B; Xu, X; Zeng, Y	1
Chon, YE; Ha, Y; Han, S; Hwang, SG; Kim, KM; Kim, MN; Lee, D; Lee, HC; Lee, JH; Lim, J; Shim, JH	1
Ogawa, E	1
Li, ZH; Liu, ZX; Luo, JX; Su, JY; Wang, YY; Wu, KJ; Wu, XL; Wu, YL; Zhong, JH	1
Aberra, H; Berhe, N; Desalegn, H; Grude, S; Gundersen, SG; Hommersand, K; Johannessen, A; Mamo, E; Orlien, SMS	1
Aladag, M; Yakut, A	1
Huang, G; Lau, WY; Li, P; Tao, Q; Wang, Y; Yu, J; Zhang, J; Zhou, W	1
Li, C; Peng, W; Qi, W; Qi, X; Wen, T; Yi, M	1
Chan, HL; Chan, SL; Choi, J; Le, A; Lim, YS; Liu, K; Nguyen, MH; Wong, GL; Wong, VW; Yip, TC	1
Chan, HL; Lui, GC; Tse, YK; Wong, GL; Wong, VW; Yip, TC	1
Chen, CH; Cheung, KS; Eguchi, Y; Enomoto, M; Furusyo, N; Hoang, J; Hsu, YC; Huang, CF; Huang, R; Huang, YT; Jang, TY; Kozuka, R; Kumada, T; Lee, DH; Li, J; Liu, C; Liu, L; Nguyen, MH; Ogawa, E; Peng, CY; Takahashi, H; Tanaka, Y; Toyoda, H; Trinh, H; Tsai, PC; Wong, C; Wong, GL; Wu, C; Xie, Q; Yang, HI; Yasuda, S; Yeh, ML; Yu, ML; Yuen, MF; Zhang, JQ; Zhao, C	1
Janjua, NZ; Krajden, M; Samji, H; Wilton, J; Yu, A	1
Bae, SH; Choi, JY; Han, NI; Jang, JW; Kwon, JH; Lee, HL; Lee, SW; Nam, HC; Nam, SW; Sung, PS; Yoo, SH; Yoon, SK	1
Lampertico, P; Papatheodoridis, GV	2
Gao, J; Yu, Y; Zhang, B; Zhang, J	1
Chen, MB; Ding, YL; Fan, JN; Niu, JL; Wang, H; Zheng, QH; Zheng, XW	1
Lee, HW	1
Li, MJ; Teng, YX; Xiang, BD; Zhong, JH	1
Arslan, F; Vahaboglu, H	1
Chan, HL; Hui, VW; Lee, HW; Liang, LY; Lui, GC; Tse, YK; Wong, GL; Wong, VW; Yip, TC	1
Li, RH; Yuan, BH; Zhu, YK	2
Wong, GL; Yip, TC	3
Choi, J; Han, S; Kim, GA; Lim, YS	1
Chow, SC; Jia, J; Kong, Y; Li, M; Lv, T; Ma, H; Ou, X; Wei, W; Wu, S; Wu, X; You, H	1
Hsu, YC; Nguyen, MH	1
Chung, RT; Holmes, JA	1
Hayakawa, Y; Higuchi, M; Inada, K; Itakura, J; Izumi, N; Kaneko, S; Kirino, S; Kurosaki, M; Maeyashiki, C; Nakanishi, H; Okada, M; Osawa, L; Sekiguchi, S; Shimizu, T; Takahashi, Y; Takaura, K; Tamaki, N; Tsuchiya, K; Wang, W; Watakabe, K; Yamashita, K; Yasui, Y	1
Berg, T; Buti, M; Calleja, JL; Chi, H; Dalekos, GN; Esteban, R; Galanis, K; Gatselis, N; Goulis, J; Hansen, BE; Idilman, R; Janssen, HLA; Keskin, O; Kourikou, A; Lampertico, P; Loglio, A; Lopez-Gomez, M; Manolakopoulos, S; Papatheodoridis, GV; Savvidou, S; Sypsa, V; Van Boemmel, F; Veelken, R; Vlachogiannakos, J; Voulgaris, T; Yurdaydin, C	1
Ahn, SH; Han, KH; Kim, BK; Kim, DY; Kim, MN; Kim, SU; Kweon, YO; Lee, EJ; Lee, HA; Lee, HW; Lee, YR; Park, JY; Park, SY; Seo, YS; Shin, HJ; Tak, WY; Um, SH	1
Ahmed, A; Kamal, F; Khan, MA; Nair, S	1
Ahn, SB; Cho, YK; Jeong, JY; Jeong, SW; Jun, DW; Kim, HS; Kim, SE; Lee, HY; Oh, H; Shim, JJ; Sohn, JH; Yoon, EL	1
Chung, JW; Ha, I; Jang, ES; Jeong, SH; Kim, JW	1
Chen, B; Chen, P; Gu, L; He, Y; Mao, F; Ng, DM; Shen, Z; Yang, T; Yao, Q; Yu, Q	1
Kim, SU; Lee, HA; Seo, YS	1
Kamal, F; Khan, MA	1
Ahn, SH; Baek, YH; Chang, Y; Choe, WH; Jang, JW; Jang, JY; Kim, GA; Kim, HY; Kim, JH; Kim, M; Kim, MA; Kim, SG; Kim, SU; Kim, YJ; Kim, YS; Koh, M; Kwon, JH; Lee, HA; Lee, HW; Lee, JH; Lee, SW; Lee, YS; Lim, YS; Park, Y; Seo, YS; Shim, JJ; Sinn, DH; Yang, H; Yim, HJ; Yoon, JH; Zoulim, F	1
Berry, K; Ioannou, GN; Su, F	1
Adams, LA; Barnard, A; Dave, S; Loomba, R; Murad, MH; Park, S; Prokop, L; Singh, S	1
Chang, HY; Kim, S; Lee, HW; Lee, JI; Lee, KS	1
Choi, J; Jo, C; Lim, YS	1
El-Serag, HB; Hsu, YC; Tseng, CH; Tseng, CM; Wu, JL	1
Shu, YF; Xu, L; Xu, XF; Yang, W	1
Ahn, SH; Han, KH; Jeon, MY; Kim, BK; Kim, DY; Kim, SU; Lee, HW; Lee, JS; Park, JY	1
Chang, KC; Hu, TH; Lin, MT; Tsai, MC; Wu, CK; Yen, YH	1
Cheong, JY; Chung, WJ; Jang, BK; Jang, JY; Jeong, SW; Kim, IH; Kim, SG; Kim, SS; Kim, SU; Kim, YS; Lee, BS; Lee, CH; Lee, HA; Lee, HW; Lee, JI; Lee, JW; Lim, TS; Park, SY; Rou, WS; Seo, YS; Suh, SJ; Tak, WY; Yim, HJ; Yu, JH	1
Choi, J; Choi, WM; Lim, YS	1
Berg, T; Buti, M; Calleja, JL; Dalekos, GN; Esteban, R; Galanis, K; Gatselis, N; Goulis, J; Hansen, BE; Idilman, R; Janssen, HLA; Kourikou, A; Lampertico, P; Loglio, A; Lopez-Gomez, M; Manolakopoulos, S; Papatheodoridi, M; Papatheodoridis, GV; Savvidou, S; Sypsa, V; Van Boemmel, F; Veelken, R; Vlachogiannakos, J; Yurdaydin, C	1
Choi, J; Lim, YS	2
Kim, BK; Kim, SU	1
Tang, X; Wang, XJ	1
Anugwom, CM; Bane, A; Braimoh, GA; Debes, JD; Sultan, A; Wondifraw, Z	1
Ge, Z; Gou, W; Ma, J; Qiao, B; Wang, Y; Zhang, H	1
Chon, YE; Ha, Y; Hwang, SG; Kim, MN; Lee, JH	1
Hsu, YC; Nguyen, MH; Tseng, CH	2
Hall, S; Howell, J; Thompson, A; Visvanathan, K	1
Con, D; Goodwin, T; Kemp, W; Majeed, A; Roberts, S	1
Lampertico, P; Papatheodoridis, G; Sypsa, V	1
Danta, M; Dore, GJ; Matthews, GV	1
Borghi, JA; Chen, IS; Chen, TH; Cheung, R; Enomoto, M; Hai, H; Hosaka, T; Hsu, YC; Ji, F; Nguyen, MH; Sezaki, H; Thuy, LTT; Tsai, YN; Tseng, CH	1
Feng, Y; Wen, Z; Yan, X	1
He, S; Xie, X; Yao, J; Yu, J; Yuan, G	1
Ahn, SH; Chang, JW; Hwang, SG; Kim, BK; Kim, DY; Kim, MN; Kim, SU; Kweon, YO; Lee, HA; Lee, HW; Lee, JS; Lee, YR; Park, JY; Park, SY; Rim, KS; Seo, YS; Tak, WY; Um, SH	1
Cheng, HM; Cheung, KS; Lai, CL; Liu, SH; Mak, LY; Seto, WK; Yuen, MF	1
Chang, KC; Chen, CH; Chien, RN; Hu, TH; Hung, CH; Kee, KM; Lin, MC; Lin, MT; Lu, SN; Tseng, PL; Wang, JH; Yueh-Hsia Chiu, S	1
Liu, Y; Mo, Y; Wu, A	1
Chang, JW; Kim, SU	1
Choi, J; Choi, WM; Han, S; Lim, YS; Wong, GL	1
Chang, TS; Chen, WM; Hsieh, YY; Hung, CH; Lee, CP; Lu, SN; Shen, CH; Tsai, ML; Tung, SY; Yang, YH; Yen, CW	1
Pol, S	1
Ahn, CH; Cho, JY; Choo, SY; Dezhbord, M; Kim, DS; Kim, JC; Kim, KH; Kim, NY; Lee, AR; Lee, JH; Park, ES; Park, S; Shin, JJ; Won, J	1
Carrat, F; Fontaine, H; Luzivika Nzinga, C; Pol, S	1
Adalı, G; Bahadır, Ö; Can, G; Değirmenci Saltürk, AG; Doğanay, HL; Gökçen, P; Güzelbulut, F; Özdil, K	1
Hao, FB; Peng, Y; Wang, CR; Wang, YQ; Yuan, J; Zhong, GC	1
Jain, MK; Kshirsagar, O; Niu, B; Thamer, M; Therapondos, G; Wong, RJ	1
Chan, HL; Hui, VW; Lui, GC; Tse, YK; Wong, GL; Wong, VW; Yip, TC	1
Ahn, SH; Kim, BK; Kim, DY; Kim, SU; Lee, JH; Park, JY; Park, SY; Sinn, DH; Tak, WY	1
Carrat, F; Lusivika Nzinga, C; Pol, S	1
Huang, R; Liu, J; Wang, J; Wu, C	1
Chen, R; Wang, JG; Wang, LC	1
Chang, KC; Chien, RN; Chiu, SY; Hu, TH	1
Choi, H; Seo, GH	1
Cho, Y; Jeong, S; Kim, W; Park, SM	1
Cho, S; Kim, GA; Kim, HJ; Ko, MJ; Lee, J; Lim, YS	1
Chang, SH	1
Sonneveld, MJ; van Erpecum, KJ	1
Choi, J; Kim, SU; Lee, SW; Lim, YS	1
Adalı, G; Aslan, E; Can, G; Değirmenci Saltürk, AG; Doğanay, HL; Gökçen, P; Güzelbulut, F; Özdil, K	1
Baek, SY; Choi, MS; Gwak, GY; Jang, HJ; Kang, WS; Kim, KA; Kim, YJ; Koh, KC; Lee, JH; Na, JE; Paik, SW; Paik, YH; Sinn, DH; Yoon, JH	1
Ahn, SH; Cho, YY; Kim, BK; Kim, DY; Kim, SU; Lee, H; Lee, HW; Lee, JS; Park, JY; Park, SY	2
He, L; Jiang, Y; Liu, X; Wang, X; Yang, Z; Zhang, S; Zhao, Y	1
Ahn, SH; Han, KH; Hwang, SG; Kim, BK; Kim, DY; Kim, MN; Kim, SU; Park, JY; Rim, KS	1
Berg, T; Buti, M; Calleja, JL; Chi, H; Colombo, M; Dalekos, GN; de la Revilla, J; Esteban, R; Galanis, K; Gatselis, N; Goulis, J; Hansen, BE; Idilman, R; Janssen, HLA; Keskın, O; Kourikou, A; Lampertico, P; Lehretz, M; Loglio, A; Manolakopoulos, S; Papatheodoridis, GV; Savvidou, S; Siakavellas, S; Sypsa, V; van Boemmel, F; Vlachogiannakos, I; Yurdaydin, C	1
Wang, Y; Zhao, LF	1
El-Serag, HB; Ho, HJ; Hsu, YC; Huang, YT; Lee, TY; Lin, JT; Wu, CY; Wu, MS	1
Iio, E; Inoue, T; Kumada, T; Matsunami, K; Murakami, S; Nojima, M; Ogawa, S; Shinkai, N; Tanaka, Y; Toyoda, H	1
Berg, T; Buti, M; Calleja, JL; Chi, H; Colombo, M; Dalekos, G; de la Revilla, J; Esteban, R; Galanis, K; Gatselis, N; Goulis, J; Hansen, BE; Idilman, R; Janssen, HLA; Keskın, O; Kourikou, A; Lampertico, P; Lehretz, M; Loglio, A; Manolakopoulos, S; Papatheodoridis, GV; Savvidou, S; Siakavellas, S; Sypsa, V; van Boemmel, F; Vlachogiannakos, I; Yurdaydin, C	1
El-Serag, HB; Ho, HJ; Hsu, YC; Huang, YT; Lee, TY; Lin, JT; Wong, GL; Wong, VW; Wu, CY; Wu, MS; Yip, TC	1
Kaplan, D	1
Henry, L; Le, A; Lee, MH; Nguyen, MH; Nguyen, N; Trinh, H; Wong, C; Yang, HI; Zhang, J	1
Flemming, JA; Terrault, NA	1
Cho, S; Choi, J; Kim, HJ; Ko, MJ; Lee, J; Lim, YS	1
Chan, HL; Lam, KL; Lui, GC; Tse, YK; Wong, GL; Wong, VW; Yip, TC	1
Chan, HLY	1
An, HY; Heo, NY; Jang, JW; Jin, YJ; Lee, JW; Suh, YJ; You, CR; Yu, JH	1
Brancaccio, G; Fasano, M; Gaeta, GB; Grossi, A; Santantonio, TA	1
Ahn, SH; Han, KH; Hwang, SG; Kim, BK; Kim, DY; Kim, MN; Kim, SU; Kweon, YO; Lee, HA; Lee, HW; Lee, YR; Park, JY; Park, SY; Rim, KS; Seo, YS; Tak, WY; Um, SH	1
Atkinson, A; Bernasconi, E; Bonnet, F; Dabis, F; Dufour, JF; Fehr, J; Gjærde, LK; Kraus, D; Mauron, E; Neau, D; Peters, L; Rauch, A; Reiss, P; Rockstroh, J; Smit, C; van der Valk, M; Wandeler, G	1
Jia, J; Kong, Y; Yang, HI	1
Choi, J; Ko, MJ; Lim, YS	1
Hou, J; Liu, Z; Sun, J	1
Zeng, W; Zhang, H	1
Hu, K; Huang, Y; Yang, J; Zhang, Z; Zhou, Y	1
Dang, Z; Jiang, Y; Liu, X; Wang, X; Yan, Z; Yu, L	1
Lampertico, P; Wong, GL	1
Ahn, SH; Han, KH; Hwang, SG; Kim, BK; Kim, DY; Kim, EH; Kim, HY; Kim, MN; Kim, SU; Kweon, YO; Lee, HA; Lee, HW; Lee, YR; Park, JY; Park, SY; Rim, KS; Seo, YS; Tak, WY; Um, SH	1
Ceriotti, F; Colombo, M; Cortinovis, I; Facchetti, F; Iavarone, M; Lampertico, P; Loglio, A; Lunghi, G; Occhipinti, V; Orenti, A; Rumi, M; Sangiovanni, A; Viganò, M	1
Kim, BK	1
Bonino, F; Brunetto, MR; Caputo, A; Coco, B; Espinos, B; Iannazzo, S; Latour, A; Rossetti, F	1
Fontana, RJ; Kuo, YF; Salameh, H; Singal, AK	1
Calvaruso, V; Craxì, A	1
Colombo, M; Della Corte, C; Triolo, M	1
Strasser, SI	1
Gervain, J; Horváth, G; Hunyady, B; Lengyel, G; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I	1
Cainelli, F; Comparcola, D; Della Corte, C; Nobili, V; Vento, S	1
Berg, T; van Bömmel, F	1
Arends, P; Buti, M; Colombo, M; Dalekos, GN; Esteban, R; Galanis, K; Gatselis, N; Goulis, J; Hansen, BE; Idilman, R; Janssen, HL; Keskın, O; Lampertico, P; Mangia, G; Manolakopoulos, S; Papaioannou, C; Papatheodoridis, GV; Savvidou, S; Sypsa, V; Yurdaydin, C	1
Alcantara, L; Burak, KW; Coffin, CS; Klein, P; Myers, RP; Pang, JX; Rezaeeaval, M	1
Akarca, US; Elhan, AH; Gulsen, M; Gunsar, F; Idilman, R; Keskin, O; Koruk, M; Meral, CE; Yurdaydin, C	1
Borsa-Lebas, F; Cacoub, P; Carrat, F; Fillion, A; Lacombe, K; Lopes, A; Loustaud-Ratti, V; Miailhes, P; Piroth, L; Pol, S; Rosenthal, E; Salmon, D	1
Chen, WD; Gong, GZ; Luo, Y; Zhou, HY	1
Afdhal, NH; Bornstein, JD; Buti, M; Dinh, P; Flaherty, JF; Flisiak, R; Fung, S; Gane, E; George, J; Gurel, S; Janssen, HL; Mani Subramanian, G; Marcellin, P; Martins, EB; Yee, LJ	1
Akıncı, H; Balık, İ; Başar, Ö; Çoban, Ş; Dökmeci, A; Güner, R; Kalkan, Ç; Örmeci, N; Özbaş, B; Özkan, H; Yalçı, A; Yüksel, İ; Yüksel, O	1
Boettler, T; Thimme, R	1
Aguilar Schall, RE; Berg, T; Buti, M; Dinh, PV; Flaherty, JF; Fung, S; Gurel, S; Jacobson, I; Kim, WR; Loomba, R; Marcellin, P; Martins, EB; Therneau, TM; Yee, LJ	1
Behera, M; Dixit, VK; Ghosh, J; Goyal, SK; Gupta, N; Jain, AK; Ranjan, A; Shukla, SK; Tripathi, M	1
Amani, A; Niederau, C; Thiel, A	1
Buti, M; Calleja, JL; Chi, H; Colombo, M; Dalekos, G; de la Revilla, J; Esteban, R; Galanis, K; Gatselis, N; Goulis, J; Hansen, BE; Idilman, R; Janssen, HL; Keskin, O; Lampertico, P; Mangia, G; Manolakopoulos, S; Papatheodoridis, G; Savvidou, S; Sypsa, V; Vlachogiannakos, I; Yurdaydin, C	1
Chang, KC; Chen, CH; Hu, TH; Hung, CH; Kee, KM; Lee, CM; Lu, SN; Tseng, PL; Wang, HM; Wang, JH; Yen, YH	1
den Eynde, EV; Riveiro-Barciela, M	1
Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Tsai, MC; Wang, JH	1
Asano, M; Dohi, T; Enomoto, N; Gatanaga, H; Honda, M; Inoue, T; Kaneko, S; Kawamura, YI; Matsumoto, A; Mizokami, M; Murata, K; Nishida, N; Oka, S; Sakamoto, M; Shirasaki, T; Shuno, Y; Sugiyama, M; Tanaka, E; Yano, H	1
Chinnaratha, MA; Fraser, RJ; Kaambwa, B; Wigg, AJ; Woodman, RJ	1
Grossi, G; Lampertico, P; Loglio, A; Viganò, M	1
Acero, D; Aguirre, A; Buti, M; Calleja, JL; Comas, C; Crespo, J; de Cuenca, B; Esteban, R; Fernandez-Bermejo, M; García-Samaniego, J; Gutierrez, ML; Lens, S; Manzano, ML; Moreno, D; Moreno-Palomares, JJ; Pascasio, JM; Piqueras, B; Riveiro-Barciela, M; Rivero, M; Rodríguez, FG; Sánchez-Pobre, P; Suárez, E; Tabernero, D	1
Buffet, C	1
Marcellin, P	1
Alberti, A; Brunetto, M; Bruno, R; Cariti, G; Carosi, G; Colombo, M; Craxì, A; Di Marco, V; Ferrari, C; Filice, G; Gaeta, GB; Lampertico, P; Levrero, M; Marzano, A; Mazzotta, F; Pastore, G; Piccinino, F; Pollicino, T; Prati, D; Puoti, M; Raimondo, G; Rizzetto, M; Sagnelli, E; Santantonio, T; Smedile, A; Toti, M	1
Hu, KQ; Pan, CQ; Tsai, N	1
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J; Sagir, A	1

Reviews

46 review(s) available for tenofovir and Liver Neoplasms

Article	Year
Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis. Gut, 2022, Volume: 71, Issue:8 Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Tenofovir; Treatment Outcome	2022
Clinical management of chronic hepatitis B: A concise overview. United European gastroenterology journal, 2022, Volume: 10, Issue:1 Topics: Aged; Antiviral Agents; Asymptomatic Diseases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Esophageal and Gastric Varices; Hepatic Encephalopathy; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Liver Neoplasms; Male; Seroconversion; Tenofovir; Withholding Treatment	2022
Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis. Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Safety of current antiviral drugs for chronic hepatitis B. Expert opinion on drug safety, 2022, Volume: 21, Issue:7 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Treatment Outcome	2022
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis. BMC cancer, 2022, Mar-17, Volume: 22, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Tenofovir; Treatment Outcome	2022
Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis. JAMA network open, 2022, 06-01, Volume: 5, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Tenofovir	2022
Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B. Viruses, 2022, 10-11, Volume: 14, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Hepatitis C; HIV Infections; Humans; Liver Neoplasms; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta-analysis. Journal of viral hepatitis, 2023, Volume: 30, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Tertiary Prevention; Treatment Outcome	2023
The Different Prognoses of Hepatocellular Carcinoma with Previous Tenofovir versus Entecavir Treatment for Chronic Hepatitis B Virus: Analysis Based on 15 Propensity Score-Matched Studies. Digestive diseases (Basel, Switzerland), 2023, Volume: 41, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Prognosis; Propensity Score; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis. Journal of hepatology, 2023, Volume: 78, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Lower risk of hepatocellular carcinoma with tenofovir than entecavir in antiviral treatment-naïve chronic hepatitis B patients: a systematic review and meta-analysis involving 90,897 participants. Clinical and experimental medicine, 2023, Volume: 23, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Meta-analysis of the occurrence of hepatocellular carcinoma after the treatment of entecavir and tenofovir for chronic hepatitis B. Medicine, 2023, Feb-10, Volume: 102, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Treatment Outcome	2023
Possible biological mechanisms of entecavir versus tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma. Journal of gastroenterology and hepatology, 2023, Volume: 38, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interleukin-10; Leukocytes, Mononuclear; Liver Neoplasms; Nucleosides; Proto-Oncogene Proteins c-akt; Tenofovir; TOR Serine-Threonine Kinases; Treatment Outcome	2023
HCC prediction models in chronic hepatitis B patients receiving entecavir or tenofovir: a systematic review and meta-analysis. Virology journal, 2023, 08-15, Volume: 20, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2023
Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis. PloS one, 2019, Volume: 14, Issue:11 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome	2019
[Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2019, Nov-25, Volume: 74, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Proportional Hazards Models; Tenofovir; Treatment Outcome	2019
Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis. Hepatology international, 2020, Volume: 14, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2020
New approaches in viraemic organ transplantation and antiviral therapies. Nature reviews. Gastroenterology & hepatology, 2020, Volume: 17, Issue:2 Topics: Aminoisobutyric Acids; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Guanine; Hepatitis B, Chronic; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Lactams, Macrocyclic; Leucine; Liver Neoplasms; Liver Transplantation; Macrocyclic Compounds; Proline; Quinoxalines; Salvage Therapy; Sofosbuvir; Sulfonamides; Tenofovir; Transplants	2020
Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Tenofovir	2020
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Observational Studies as Topic; Randomized Controlled Trials as Topic; Risk; Tenofovir	2021
Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Comorbidity; Female; Forecasting; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Risk; Tenofovir	2020
Hepatocellular carcinoma and multiple myeloma with elevated globulin: a case report and literature review. The Journal of international medical research, 2020, Volume: 48, Issue:5 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Hepatocellular; Diagnosis, Differential; DNA, Viral; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Radiofrequency Ablation; Tenofovir; Ultrasonography	2020
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021, Volume: 19, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Treatment Outcome	2021
The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy. Viruses, 2020, 08-25, Volume: 12, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Duration of Therapy; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Public Health Practice; Tenofovir; Treatment Outcome; Viral Load; Withholding Treatment	2020
Comparison of 48-week efficacy of tenofovir vs entecavir for patients with chronic hepatitis B: A network meta-analysis. Journal of viral hepatitis, 2021, Volume: 28, Issue:1 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Network Meta-Analysis; Tenofovir	2021
Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis. The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Tenofovir	2020
Entecavir vs Tenofovir in Hepatocellular Carcinoma Prevention in Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis. Clinical and translational gastroenterology, 2020, Volume: 11, Issue:10 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Observational Studies as Topic; Risk Assessment; Tenofovir; Treatment Outcome	2020
No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis. Aging, 2021, 02-26, Volume: 13, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Risk Factors; Tenofovir	2021
Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy: A Systematic Review and Meta-analysis. Journal of clinical gastroenterology, 2021, 10-01, Volume: 55, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Tenofovir; Treatment Outcome	2021
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma. Clinical and molecular hepatology, 2021, Volume: 27, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Treatment Outcome	2021
Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Disease markers, 2017, Volume: 2017 Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Organophosphonates; Retrospective Studies; Survival Analysis; Telbivudine; Tenofovir; Thymidine	2017
Okuda lecture: Challenges of hepatitis B in the era of antiviral therapy. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:3 Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Immune Tolerance; Liver Neoplasms; Nucleotides; Tenofovir; Withholding Treatment	2019
The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis. BMC cancer, 2019, May-29, Volume: 19, Issue:1 Topics: Adult; Carcinoma, Hepatocellular; Controlled Clinical Trials as Topic; Female; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Retrospective Studies; Tenofovir	2019
Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis. Gut and liver, 2020, 03-15, Volume: 14, Issue:2 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Nucleotides; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome	2020
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B. Alimentary pharmacology & therapeutics, 2013, Volume: 38, Issue:2 Topics: Adenine; Administration, Oral; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Treatment Outcome	2013
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1 Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine	2014
Impact of HBV therapy on the incidence of hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34 Suppl 1 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Tenofovir	2014
Managing hepatitis B to prevent liver cancer: recent advances. Expert review of gastroenterology & hepatology, 2014, Volume: 8, Issue:4 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2014
Management of chronic hepatitis B in children: an unresolved issue. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:5 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Carrier State; Child; Databases, Bibliographic; Guanine; Hepatitis B, Chronic; Humans; Immune Tolerance; Incidence; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Risk; Tenofovir	2014
Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Databases, Bibliographic; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Regression Analysis; Tenofovir	2015
[Management and treatment of patients with hepatitis B]. Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34 Suppl 3 Topics: Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Tenofovir	2016
Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs). Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37 Suppl 1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Safety; Sustained Virologic Response; Tenofovir	2017
[Chronic hepatitis B: current therapy]. Bulletin de l'Academie nationale de medecine, 2008, Volume: 192, Issue:8 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Guanine; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Immunotherapy, Active; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir; Treatment Outcome	2008
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011, Volume: 43, Issue:4 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Italy; Liver Cirrhosis; Liver Neoplasms; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2011
Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients. Antiviral therapy, 2013, Volume: 18, Issue:7 Topics: Adenine; Antiviral Agents; Asian People; Carcinoma, Hepatocellular; Disease Progression; Drug Resistance, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Organophosphonates; Tenofovir; Treatment Outcome	2013
[New approaches in the treatment of hepatitis B]. Deutsche medizinische Wochenschrift (1946), 2004, May-21, Volume: 129, Issue:21 Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine	2004

Trials

7 trial(s) available for tenofovir and Liver Neoplasms

Article	Year
Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial. International journal of surgery (London, England), 2023, Oct-01, Volume: 109, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B, Chronic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Prognosis; Tenofovir; Treatment Outcome	2023
The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial. Trials, 2023, Dec-02, Volume: 24, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B. Scientific reports, 2021, 01-14, Volume: 11, Issue:1 Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Risk Factors; Tenofovir; Time Factors	2021
Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prospective Studies; Tenofovir; Treatment Outcome	2021
Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting. Journal of viral hepatitis, 2015, Volume: 22, Issue:5 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Creatinine; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load	2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years. Hepatology international, 2015, Volume: 9, Issue:2 Topics: Adult; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Retrospective Studies; Tenofovir; Time Factors; Viral Load	2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Cancer, 2015, Oct-15, Volume: 121, Issue:20 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Double-Blind Method; Drug Administration Schedule; Female; Hepatitis B, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Risk Assessment; Tenofovir	2015

Other Studies

151 other study(ies) available for tenofovir and Liver Neoplasms

Article	Year
Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments. Journal of hepatology, 2022, Volume: 76, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Meta-Analysis as Topic; Proportional Hazards Models; Research Design; Risk Assessment; Tenofovir; Treatment Outcome	2022
Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir. Medicine, 2021, Oct-01, Volume: 100, Issue:39 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Tenofovir	2021
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B. Journal of hepatology, 2022, Volume: 76, Issue:2 Topics: Adult; Antiviral Agents; Artificial Intelligence; Asian People; Carcinoma, Hepatocellular; Cohort Studies; Computer Simulation; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Republic of Korea; Tenofovir; White People	2022
Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection: A multicenter study. Cancer medicine, 2021, Volume: 10, Issue:23 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatectomy; Hepatitis B virus; Humans; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nucleosides; Nucleotides; Prognosis; Retrospective Studies; Survival Analysis; Tenofovir	2021
Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B. Intervirology, 2022, Volume: 65, Issue:2 Topics: Alanine; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients. Hepatology international, 2021, Volume: 15, Issue:6 Topics: Aged; Alanine; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Tenofovir; Treatment Outcome	2021
Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy. Chinese medical journal, 2021, Dec-21, Volume: 135, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatectomy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Retrospective Studies; Tenofovir	2021
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:7 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Retrospective Studies; Tenofovir; Treatment Outcome; United States	2022
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection. Journal of gastroenterology, 2022, Volume: 57, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Retrospective Studies; Tenofovir; Treatment Outcome	2022
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment. World journal of gastroenterology, 2022, Feb-14, Volume: 28, Issue:6 Topics: Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Risk Factors; Tenofovir	2022
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:7 Topics: Adenine; Alanine; Carcinoma, Hepatocellular; Female; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Tenofovir	2022
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation. Viruses, 2022, 03-22, Volume: 14, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Radiofrequency Ablation; Retrospective Studies; Tenofovir; Treatment Outcome	2022
Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in Taiwan. Clinical therapeutics, 2022, Volume: 44, Issue:3 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Prognosis; Taiwan; Tenofovir; Treatment Outcome	2022
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:10 Topics: Carcinoma, Hepatocellular; Guanine; Humans; Liver Neoplasms; Tenofovir	2022
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-a "knock-out" is yet to be delivered. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Humans; Liver Neoplasms; Tenofovir	2022
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study. Hepatology international, 2022, Volume: 16, Issue:4 Topics: Antiviral Agents; Cohort Studies; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tenofovir; Treatment Outcome	2022
Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma. European journal of internal medicine, 2022, Volume: 103 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Tenofovir; Treatment Outcome	2022
Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis. BMC infectious diseases, 2022, Jul-14, Volume: 22, Issue:1 Topics: Adenine; Alanine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Retrospective Studies; Tenofovir	2022
Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir. The Tohoku journal of experimental medicine, 2022, Nov-12, Volume: 258, Issue:4 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Fumarates; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Treatment Outcome	2022
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection. Journal of hepatology, 2023, Volume: 78, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; Hepatitis B virus; HIV Infections; Humans; Liver Neoplasms; Tenofovir	2023
Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma. Chinese medical journal, 2023, 10-05, Volume: 136, Issue:19 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Treatment Outcome; Viral Load	2023
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:11 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Mellitus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Risk Factors; Tenofovir	2023
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study. The American journal of gastroenterology, 2023, 11-01, Volume: 118, Issue:11 Topics: Antiviral Agents; Artificial Intelligence; Carcinoma, Hepatocellular; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Machine Learning; Male; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy. Alimentary pharmacology & therapeutics, 2023, Volume: 57, Issue:11 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Tenofovir; Treatment Outcome	2023
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma. BMC cancer, 2023, Mar-13, Volume: 23, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B virus; Humans; Liver Neoplasms; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Viral hepatitis in persons living with HIV in the post-COVID era. AIDS reviews, 2023, Volume: 25, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; COVID-19; Drug Users; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Sexual and Gender Minorities; Substance Abuse, Intravenous; Tenofovir	2023
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years. Alimentary pharmacology & therapeutics, 2023, Volume: 57, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Esophageal and Gastric Varices; Female; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Tenofovir; Treatment Outcome; Varicose Veins	2023
The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy. BMC gastroenterology, 2023, May-19, Volume: 23, Issue:1 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; DNA, Viral; Drug Therapy, Combination; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Interleukin-1beta; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Prospective Studies; Tenofovir; Treatment Outcome	2023
Aldo-keto reductase family 1 member B10 is regulated by nucleos(t)ide analogues for chronic hepatitis B. Biochemical and biophysical research communications, 2023, 09-24, Volume: 674 Topics: Aldo-Keto Reductase Family 1 member B10; Aldo-Keto Reductases; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Tenofovir	2023
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:8 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir	2023
Entecavir versus tenofovir on the recurrence of hepatitis B-related HCC after liver transplantation: A multicenter observational study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2023, Dec-01, Volume: 29, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Tenofovir; Treatment Outcome	2023
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study. The Lancet. Global health, 2023, Volume: 11, Issue:9 Topics: Adult; Africa, Western; Antiviral Agents; Carcinoma, Hepatocellular; Female; Gambia; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Retrospective Studies; Tenofovir; Treatment Outcome	2023
Five-year on-treatment variables-based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir-treated patients. International journal of cancer, 2023, 12-15, Volume: 153, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Retrospective Studies; Risk Factors; Tenofovir; Treatment Outcome	2023
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy-Author's reply. Alimentary pharmacology & therapeutics, 2023, Volume: 58, Issue:8 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipoproteins; Liver Neoplasms; Tenofovir; Treatment Outcome	2023
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy. Alimentary pharmacology & therapeutics, 2023, Volume: 58, Issue:8 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipoproteins; Liver Neoplasms; Tenofovir; Treatment Outcome	2023
Five-year results of a treatment program for chronic hepatitis B in Ethiopia. BMC medicine, 2023, 09-29, Volume: 21, Issue:1 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Ethiopia; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Tenofovir	2023
The relationship between the use of nucleos(t)ide analogs and metabolic parameters in patients with chronic hepatitis B. European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:19 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Glycated Hemoglobin; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Tenofovir; Treatment Outcome	2023
Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection. JAMA network open, 2023, 10-02, Volume: 6, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; China; Hepatitis B virus; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir; Tertiary Care Centers	2023
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:9 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Survival Analysis; Tenofovir; Treatment Outcome	2019
Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China. Gastroenterology, 2020, Volume: 158, Issue:1 Topics: Adult; Aftercare; Antiviral Agents; Carcinoma, Hepatocellular; China; Disease Progression; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome	2020
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B. The American journal of gastroenterology, 2020, Volume: 115, Issue:2 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; China; Cohort Studies; Disease Progression; Female; Guanine; Hepatitis B, Chronic; Hong Kong; Humans; International Cooperation; Japan; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Taiwan; Tenofovir; Treatment Outcome; United States	2020
Reply to: "Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis". Journal of hepatology, 2019, Volume: 71, Issue:6 Topics: Carcinoma, Hepatocellular; Delayed Diagnosis; Hepatitis B, Chronic; Humans; Liver Neoplasms; Mutation; Tenofovir	2019
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis. Gut, 2020, Volume: 69, Issue:7 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cause of Death; Female; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Propensity Score; Republic of Korea; Risk; Tenofovir	2020
Is Tenofovir Superior to Entecavir in Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B? The Controversy Continues. Gastroenterology, 2020, Volume: 158, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; China; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2020
Comment on - A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea. Journal of hepatology, 2020, Volume: 72, Issue:1 Topics: Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Republic of Korea; Tenofovir	2020
Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis. Gut, 2020, Volume: 69, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Propensity Score; Republic of Korea; Tenofovir	2020
Tenofovir for the Prevention of HCC in Patients With Cirrhosis. The American journal of gastroenterology, 2020, Volume: 115, Issue:2 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Tenofovir	2020
Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B. Journal of hepatology, 2020, Volume: 72, Issue:5 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hong Kong; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Prognosis; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Serologic Tests; Tenofovir	2020
Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:2 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Humans; Liver Cirrhosis; Liver Neoplasms; Tenofovir; Virus Replication	2020
Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:2 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Humans; Liver Cirrhosis; Liver Neoplasms; Tenofovir; Virus Replication	2020
Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B. The American journal of gastroenterology, 2020, Volume: 115, Issue:3 Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Risk; Tenofovir; Treatment Outcome	2020
Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. The American journal of gastroenterology, 2020, Volume: 115, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Telomerase; Tenofovir	2020
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:9 Topics: Adenine; Adult; Alanine; Antiviral Agents; Asian People; Carcinoma, Hepatocellular; Cohort Studies; Female; Guanine; Hepatitis B, Chronic; Humans; Japan; Liver Neoplasms; Male; Middle Aged; Nucleotides; Platelet Count; Research Design; Risk; Tenofovir; Time Factors	2020
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B. Journal of hepatology, 2020, Volume: 72, Issue:6 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Risk Factors; Tenofovir; Treatment Outcome; White People; Young Adult	2020
Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020, Volume: 29, Issue:4 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver; Liver Neoplasms; Male; Middle Aged; Molecular Typing; Republic of Korea; Risk Adjustment; Risk Factors; Tenofovir; Time Factors	2020
Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B. Gut, 2020, Volume: 69, Issue:11 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Propensity Score; Republic of Korea; Tenofovir	2020
No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir vs Tenofovir. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Retrospective Studies; Tenofovir; Treatment Outcome	2020
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:10 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Propensity Score; Retrospective Studies; Risk; Tenofovir	2020
Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B. Gastroenterology, 2020, Volume: 158, Issue:8 Topics: Antiviral Agents; Carcinoma, Hepatocellular; China; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2020
Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir? Gastroenterology, 2020, Volume: 158, Issue:8 Topics: Antiviral Agents; Carcinoma, Hepatocellular; China; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2020
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study. Gut, 2020, Volume: 69, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Sustained Virologic Response; Tenofovir	2020
No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir. Gut, 2021, Volume: 70, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tenofovir	2021
Reply. Gastroenterology, 2020, Volume: 158, Issue:8 Topics: Carcinoma, Hepatocellular; China; Guanine; Hepatitis B virus; Humans; Liver Neoplasms; Tenofovir	2020
Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance. BMC gastroenterology, 2020, Apr-18, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir; Young Adult	2020
Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:2 Topics: Aged; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Disease-Free Survival; Follow-Up Studies; Guanine; Hepatectomy; Hepatitis B, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Tenofovir	2021
Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma. Journal of viral hepatitis, 2020, Volume: 27, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Creatinine; Female; Glomerular Filtration Rate; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Kidney Function Tests; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome	2020
Comparison of tenofovir and entecavir in the development of acute kidney injury in cirrhotic chronic hepatitis B patients with refractory ascites. European journal of gastroenterology & hepatology, 2021, 02-01, Volume: 32, Issue:2 Topics: Acute Kidney Injury; Antiviral Agents; Ascites; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Retrospective Studies; Tenofovir; Treatment Outcome	2021
Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir. Journal of viral hepatitis, 2020, Volume: 27, Issue:10 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Tenofovir	2020
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B. Journal of hepatology, 2020, Volume: 73, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Elasticity Imaging Techniques; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Risk Assessment; Tenofovir; White People	2020
REPLY. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:1 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Tenofovir	2021
Letter to the Editor: Re: Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:1 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Tenofovir	2021
REPLY. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:1 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Tenofovir	2021
Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa. Expert review of gastroenterology & hepatology, 2020, Volume: 14, Issue:10 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; End Stage Liver Disease; Ethiodized Oil; Ethiopia; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Retrospective Studies; Severity of Illness Index; Sorafenib; Survival Rate; Tenofovir; Treatment Outcome	2020
Impact of tenofovir antiviral treatment on survival of chronic hepatitis B related hepatocellular carcinoma after hepatectomy in Chinese individuals from Qingdao municipality. Medicine, 2020, Aug-07, Volume: 99, Issue:32 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; China; Cohort Studies; Female; Hepatectomy; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tenofovir; Treatment Outcome	2020
Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate. Scientific reports, 2020, 08-11, Volume: 10, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Survival Rate; Tenofovir; Treatment Outcome; Viral Load; Young Adult	2020
Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on. Hepatology international, 2020, Volume: 14, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Humans; Liver Neoplasms; Tenofovir	2020
Reply to: "Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B". Journal of hepatology, 2021, Volume: 74, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Hepatocellular carcinoma risk with antivirals for chronic hepatitis B: no longer confounding. The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:12 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Tenofovir	2020
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B. Journal of hepatology, 2021, Volume: 74, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Letter to the Editor: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:3 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Tenofovir	2021
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir. Journal of viral hepatitis, 2021, Volume: 28, Issue:1 Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Infant, Newborn; Liver Neoplasms; Male; Retrospective Studies; Tenofovir	2021
HCC risk reduction with oral nucleos(t)ide analogues in patients with chronic hepatitis B: Not perfect, not good enough. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:10 Topics: Adenine; Administration, Oral; Alanine; Carcinoma, Hepatocellular; DNA, Viral; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Nucleotides; Tenofovir	2020
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Alimentary pharmacology & therapeutics, 2020, Volume: 52, Issue:11-12 Topics: Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Taiwan; Tenofovir	2020
Additional more factors should be included in predicting risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Journal of viral hepatitis, 2021, Volume: 28, Issue:3 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Authors' response: Additional more factors should be included in predicting risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Journal of viral hepatitis, 2021, Volume: 28, Issue:3 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B. The lancet. Gastroenterology & hepatology, 2021, Volume: 6, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Tenofovir	2021
Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply. The lancet. Gastroenterology & hepatology, 2021, Volume: 6, Issue:2 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Tenofovir	2021
Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes. International journal of molecular sciences, 2021, Feb-05, Volume: 22, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Drug Resistance, Viral; Female; Genes, Viral; Hep G2 Cells; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Liver Neoplasms; Middle Aged; Point Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir; Viral Proteins; Virus Replication	2021
Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Europe; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Editorial: similar risk of hepatocellar carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Europe; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy. Journal of viral hepatitis, 2021, Volume: 28, Issue:5 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems. The American journal of gastroenterology, 2021, 07-01, Volume: 116, Issue:7 Topics: Adult; Aged; Alanine; Antiviral Agents; Asian; Black or African American; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mortality; Propensity Score; Proportional Hazards Models; Retrospective Studies; Safety-net Providers; Tenofovir; United States; Urban Population; White People	2021
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:2 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Humans; Liver Neoplasms; Tenofovir	2022
Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog. Clinical and translational gastroenterology, 2021, 03-23, Volume: 12, Issue:3 Topics: Adult; Aged; Alanine; Antiviral Agents; Aspirin; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Guanine; Hepatitis B, Chronic; Hong Kong; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir	2021
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma. European journal of internal medicine, 2021, Volume: 89 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Tenofovir; Treatment Outcome	2021
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:9 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Taiwan; Tenofovir	2021
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:9 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:9 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Taiwan; Tenofovir	2021
Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naïve Chronic Hepatitis B Patients in Korea. Journal of Korean medical science, 2021, Apr-12, Volume: 36, Issue:14 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Databases, Factual; Female; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Tenofovir; Young Adult	2021
Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study. Journal of viral hepatitis, 2021, Volume: 28, Issue:8 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir; Treatment Outcome	2021
Prevention of HBV Recurrence After Liver Transplant: Long-Term Results. Transplantation proceedings, 2021, Volume: 53, Issue:5 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tenofovir	2021
Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred? European journal of internal medicine, 2021, Volume: 89 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Tenofovir	2021
Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in Turkey. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2021, Volume: 32, Issue:4 Topics: Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; Tenofovir; Turkey	2021
Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response. Journal of viral hepatitis, 2021, Volume: 28, Issue:10 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Pharmaceutical Preparations; Retrospective Studies; Tenofovir; Treatment Outcome	2021
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B. Hepatology international, 2021, Volume: 15, Issue:5 Topics: Alanine; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Retrospective Studies; Tenofovir; Treatment Outcome	2021
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B. Journal of viral hepatitis, 2021, Volume: 28, Issue:11 Topics: Alanine; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Tenofovir	2021
Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:12 Topics: Adult; Antiviral Agents; Asian People; Carcinoma, Hepatocellular; Cohort Studies; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Models, Theoretical; Risk Assessment; Tenofovir	2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology (Baltimore, Md.), 2017, Volume: 66, Issue:5 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Europe; Female; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Risk Factors; Tenofovir; White People	2017
[Effect of clinical first-line Antiviral Agents on outcome of chronic hepatitis B treatment]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017, Jul-20, Volume: 25, Issue:7 Topics: Antiviral Agents; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Liver Cirrhosis; Liver Neoplasms; Tenofovir; Treatment Outcome	2017
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir. Journal of viral hepatitis, 2018, Volume: 25, Issue:5 Topics: Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Comorbidity; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Risk Assessment; Sex Factors; Taiwan; Tenofovir	2018
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues. Journal of gastroenterology, 2018, Volume: 53, Issue:7 Topics: Adult; alpha-Fetoproteins; Antigens, Neoplasm; Antiviral Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Carrier Proteins; Female; Follow-Up Studies; Glycoproteins; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Japan; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Research Design; Retrospective Studies; Sex Factors; Tenofovir	2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population. Journal of hepatology, 2018, Volume: 68, Issue:6 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Tenofovir	2018
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B. Journal of hepatology, 2018, Volume: 69, Issue:2 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Data Accuracy; Female; Guanine; Hepatitis B, Chronic; Hong Kong; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Research Design; Risk Assessment; Risk Factors; Taiwan; Tenofovir	2018
Causal Inference for Observational Studies. The Journal of infectious diseases, 2019, 01-01, Volume: 219, Issue:1 Topics: Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Propensity Score; Tenofovir	2019
Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study. The Journal of infectious diseases, 2019, 01-01, Volume: 219, Issue:1 Topics: Adult; Alanine Transaminase; Antiviral Agents; Asian People; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Retrospective Studies; Taiwan; Tenofovir	2019
Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B: One of These Things Is Not Like the Other. JAMA oncology, 2019, 01-01, Volume: 5, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Republic of Korea; Tenofovir	2019
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study. JAMA oncology, 2019, 01-01, Volume: 5, Issue:1 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cause of Death; Databases, Factual; Female; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Protective Factors; Republic of Korea; Risk Factors; Tenofovir; Time Factors; Treatment Outcome	2019
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues. Journal of hepatology, 2019, Volume: 70, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hong Kong; Humans; Liver Neoplasms; Male; Middle Aged; Outcome and Process Assessment, Health Care; Retrospective Studies; Risk Assessment; Seroepidemiologic Studies; Sustained Virologic Response; Tenofovir	2019
Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir. European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:7 Topics: Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Serum Albumin; Sex Factors; Tenofovir	2019
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:8 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis D, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome	2019
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea. Journal of hepatology, 2019, Volume: 71, Issue:3 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prognosis; Propensity Score; Republic of Korea; Retrospective Studies; Tenofovir; Treatment Outcome	2019
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies. Journal of hepatology, 2019, Volume: 71, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Carcinoma, Hepatocellular; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Tenofovir	2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B. JAMA oncology, 2019, 06-01, Volume: 5, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Republic of Korea; Tenofovir	2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B-in Reply. JAMA oncology, 2019, 06-01, Volume: 5, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Republic of Korea; Tenofovir	2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B. JAMA oncology, 2019, 06-01, Volume: 5, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Republic of Korea; Tenofovir	2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B. JAMA oncology, 2019, 06-01, Volume: 5, Issue:6 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Republic of Korea; Tenofovir	2019
Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB - Is one NUC better than the other? Journal of hepatology, 2019, Volume: 71, Issue:3 Topics: Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Republic of Korea; Tenofovir	2019
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:3 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir	2020
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy. Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:10 Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Italy; Liver Cirrhosis; Liver Neoplasms; Longitudinal Studies; Male; Middle Aged; Tenofovir; Young Adult	2019
Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction. Journal of hepatology, 2019, Volume: 71, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Republic of Korea; Tenofovir	2019
Reply to: "Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction". Journal of hepatology, 2019, Volume: 71, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prognosis; Republic of Korea; Tenofovir	2019
Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis. Antiviral therapy, 2013, Volume: 18, Issue:4 Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Drug Administration Schedule; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Male; Markov Chains; Organophosphonates; Polyethylene Glycols; Precision Medicine; Prognosis; Quality-Adjusted Life Years; Recombinant Proteins; Tenofovir; Viral Load	2013
[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline]. Orvosi hetilap, 2014, Volume: 155 Suppl Topics: Adenine; Antiviral Agents; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Hungary; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir	2014
Antiviral therapy of chronic hepatitis B. Intervirology, 2014, Volume: 57, Issue:3-4 Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Gene Products, pol; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Cirrhosis; Liver Neoplasms; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Telbivudine; Tenofovir; Thymidine; Treatment Outcome; Virus Replication	2014
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir. Journal of hepatology, 2015, Volume: 62, Issue:2 Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Greece; Guanine; Hepatitis B, Chronic; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Netherlands; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Spain; Tenofovir; Time Factors; Turkey; White People	2015
The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy. Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:11-12 Topics: Adenine; Adult; Antiviral Agents; Canada; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Nucleosides; Organophosphonates; Retrospective Studies; Risk Factors; Telbivudine; Tenofovir; Thymidine	2014
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:8 Topics: Adult; Antiviral Agents; Cohort Studies; Comorbidity; Disease Progression; Female; France; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Reference Values; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Tenofovir; Treatment Outcome	2015
Tenofovir-best hope for treatment of chronic hepatitis B infection? The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2015, Volume: 26, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Seroconversion; Tenofovir; Treatment Outcome; Young Adult	2015
Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis. Digestive diseases (Basel, Switzerland), 2015, Volume: 33, Issue:4 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Tenofovir	2015
Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2015, Volume: 34, Issue:4 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome; Young Adult	2015
Long-term follow-up of HBsAg-positive patients in Germany. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:1 Topics: Adenine; Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Mass Screening; Middle Aged; Organophosphonates; Prognosis; Prospective Studies; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Time Factors; Turkey	2016
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. Journal of hepatology, 2016, Volume: 64, Issue:4 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Risk; Tenofovir	2016
Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:7 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Comorbidity; Diabetes Mellitus; Female; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Nucleosides; Nucleotides; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome	2016
Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs. Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:7 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Telbivudine; Tenofovir; Thymidine; Treatment Outcome	2017
Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut, 2018, Volume: 67, Issue:2 Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asymptomatic Infections; Carcinoma, Hepatocellular; Culture Media, Conditioned; DNA, Viral; Female; Gene Expression; Genotype; Guanine; Hep G2 Cells; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HT29 Cells; Humans; Interferons; Interleukins; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Polymorphism, Genetic; Recombinant Proteins; Tenofovir; Up-Regulation; Young Adult	2018
Assessing the clinical and economic impact of increasing treatment uptake in chronic hepatitis B infection using a Markov model. Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:7 Topics: Antiviral Agents; Australia; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Hepatitis B, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Markov Chains; Quality of Life; Tenofovir; Time Factors; Treatment Outcome	2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma. Digestive diseases and sciences, 2017, Volume: 62, Issue:3 Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Research Design; Risk Assessment; Spain; Tenofovir; Treatment Outcome	2017
[Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines]. MMW Fortschritte der Medizin, 2009, May-28, Volume: 151, Issue:22 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Drug Resistance, Viral; Evidence-Based Medicine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Organophosphonates; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load	2009
[Treatment has a positive impact on the long-term evolution of chronic hepatitis B]. Gastroenterologie clinique et biologique, 2010, Volume: 34 Suppl 2 Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir	2010